---
figid: PMC8650509__fphar-12-757161-g002
figtitle: Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic
  Target of Parkinson’s Disease
organisms:
- herbal medicine
- Olea europaea
- Theobroma cacao
- Allium sativum
- Saccharum officinarum
- Carica papaya
- Trifolium pratense
- Paeonia lactiflora
- Gastrodia elata
- Bacopa monnieri
- Mucuna pruriens
- Polygonatum sibiricum
- Perilla frutescens var. crispa
- Neocheiropteris fortunei
- Fragaria viridis
- Trifolium pratense subsp. pratense
- Davallia mariesii
- Maianthemum trifolium
- Amelanchier arborea
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
- Caenorhabditis elegans
- Homo sapiens
- Bos taurus
- Danio rerio
- Lactobacillus gasseri
organisms_ner:
- Drosophila melanogaster
- Mus musculus
pmcid: PMC8650509
filename: fphar-12-757161-g002.jpg
figlink: /pmc/articles/PMC8650509/figure/F2/
number: F2
caption: Schematic presentation of the mitochondrial electron transport chain and
  production of mitochondrial O2•−. The mitochondrial electron transport chain produces
  ROS. Mitochondrial complexes I and II use electrons donated from NADH and FADH2
  to reduce coenzyme Q. Coenzyme Q shuttles these electrons to complex III, where
  they are transferred to cytochrome c. Complex IV uses electrons from cytochrome
  c to reduce molecular oxygen to water. The action of complexes I, III, and IV produce
  a proton electrochemical potential gradient, the free energy of which is used to
  phosphorylate ADP at ATP synthase. Complexes I, II, and III produce superoxide through
  the incomplete reduction of oxygen to superoxide, whereas complexes I and II produce
  superoxide only into the mitochondrial matrix and complex III produces superoxide
  into both the matrix and the intermembrane space.
papertitle: Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic
  Target of Parkinson’s Disease.
reftext: Yumin Wang, et al. Front Pharmacol. 2021;12:757161.
year: '2021'
doi: 10.3389/fphar.2021.757161
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: Parkinson’s disease | oxidative stress | Nrf2 | heme oxygenase-1 | neuroprotection
automl_pathway: 0.9418513
figid_alias: PMC8650509__F2
figtype: Figure
redirect_from: /figures/PMC8650509__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8650509__fphar-12-757161-g002.html
  '@type': Dataset
  description: Schematic presentation of the mitochondrial electron transport chain
    and production of mitochondrial O2•−. The mitochondrial electron transport chain
    produces ROS. Mitochondrial complexes I and II use electrons donated from NADH
    and FADH2 to reduce coenzyme Q. Coenzyme Q shuttles these electrons to complex
    III, where they are transferred to cytochrome c. Complex IV uses electrons from
    cytochrome c to reduce molecular oxygen to water. The action of complexes I, III,
    and IV produce a proton electrochemical potential gradient, the free energy of
    which is used to phosphorylate ADP at ATP synthase. Complexes I, II, and III produce
    superoxide through the incomplete reduction of oxygen to superoxide, whereas complexes
    I and II produce superoxide only into the mitochondrial matrix and complex III
    produces superoxide into both the matrix and the intermembrane space.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - so
  - Sod2
  - Sod1
  - PHGPx
  - Cat
  - Ca-alpha1T
  - ChAT
  - sv
  - omm
  - ATPsynbeta
  - Atpalpha
  - Prdx6
  - Gpx1
  - Gpx3
  - cac
  - Mip
  - Trpv6
  - Glyat
  - H20
---
